From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Apr 28, 2004
MDL Docket No. 1290, Misc. No. 99mc0276 (D.D.C. Apr. 28, 2004)

Opinion

MDL Docket No. 1290, Misc. No. 99mc0276

April 28, 2004


ORDER


For the reasons stated from the bench at the status hearing on April 21, 2004, the status hearing previously scheduled for May 5, 2004 is rescheduled for Thursday, May 20, 2004 at 4:30 p.m. Accordingly, it is hereby

ORDERED that this case shall now proceed within the following schedule:

1. Deadline for Defendants' Expert Reports 05/19/04

2. Status Hearing 05/20/04 at 4:30 p.m.

3. Deadline for Plaintiffs'Rebuttal 06/09/04

4. Status Hearing 06/23/04 at 10:00 a.m.

5. Close of Expert Discovery 07/02/04

6. Deadline to Submit Dispositive Motions 07/23/04

7. Deadline to Submit Oppositions 08/13/04

8. Deadline to Submit Replies 08/27/04

9. Pretrial Conference 11/23/04 at 10:00 a.m. 10. Trial 01/04/05 at 9:30 a.m.
SO ORDERED.


Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Apr 28, 2004
MDL Docket No. 1290, Misc. No. 99mc0276 (D.D.C. Apr. 28, 2004)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:IN RE LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION, This Order applies to…

Court:United States District Court, D. Columbia

Date published: Apr 28, 2004

Citations

MDL Docket No. 1290, Misc. No. 99mc0276 (D.D.C. Apr. 28, 2004)